What’s new

Researchers Design Safer Drug Candidate for Chronic Pain and Pruritus

Recently, a research team from the Hefei Institute of Physical Science of the Chinese Academy of Sciences (CAS), in collaboration with the Shanghai Institute of Materia Medica, CAS, developed a kappa opioid receptor (KOR) biased agonist with high efficacy and reduced side effects through structure-based rational design. The study was supported by the Steady High Magnetic Field Facility (SHMFF), including a 9.4 T m...